BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14695626)

  • 1. Stem cell transplantation post invasive fungal infection is a feasible task.
    Avivi I; Oren I; Haddad N; Rowe JM; Dann EJ
    Am J Hematol; 2004 Jan; 75(1):6-11. PubMed ID: 14695626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation in patients with active fungal infection: not a contraindication for transplantation.
    Aki ZS; Sucak GT; Yeğin ZA; Güzel O; Erbaş G; Senol E
    Transplant Proc; 2008 Jun; 40(5):1579-85. PubMed ID: 18589155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey.
    Sinkó J; Csomor J; Nikolova R; Lueff S; Kriván G; Reményi P; Bátai A; Masszi T
    Transpl Infect Dis; 2008 Apr; 10(2):106-9. PubMed ID: 17605727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases.
    Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR
    Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic SCT in patients with a history of invasive fungal infection.
    Zhang P; Song A; Wang Z; Feng S; Qiu L; Han M
    Bone Marrow Transplant; 2009 Apr; 43(7):533-7. PubMed ID: 19104496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.
    Castroagudín JF; Pontón C; Bustamante M; Otero E; Martínez J; Tomé S; Conde R; Segade FR; Delgado M; Brage A; Galbán C; Varo E
    Transplant Proc; 2005 Nov; 37(9):3965-7. PubMed ID: 16386598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal infection in heart transplant recipients with severe sepsis: single-center experience.
    Chou NK; Chi NH; Wu IW; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Sun HY; Chang SC; Chu SH; Wang SS
    Transplant Proc; 2010 Apr; 42(3):952-4. PubMed ID: 20430214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
    Rieger CT; Rieger H; Kolb HJ; Peterson L; Huppmann S; Fiegl M; Ostermann H
    Transpl Infect Dis; 2009 Jun; 11(3):220-6. PubMed ID: 19298239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and monitoring of invasive fungal infections in pediatric patients with cancer and hematologic disorders.
    Hovi L; Saxen H; Saarinen-Pihkala UM; Vettenranta K; Meri T; Richardson M
    Pediatr Blood Cancer; 2007 Jan; 48(1):28-34. PubMed ID: 16395687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum and risk factors for invasive candidiasis and non-Candida fungal infections after liver transplantation.
    Shi SH; Lu AW; Shen Y; Jia CK; Wang WL; Xie HY; Zhang M; Liang TB; Zheng SS
    Chin Med J (Engl); 2008 Apr; 121(7):625-30. PubMed ID: 18466683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal osteoarticular infections in patients treated at a comprehensive cancer centre: a 10-year retrospective review.
    Kumashi PR; Safdar A; Chamilos G; Chemaly RF; Raad II; Kontoyiannis DP
    Clin Microbiol Infect; 2006 Jul; 12(7):621-6. PubMed ID: 16774557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of non-Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001).
    Safdar A; Singhal S; Mehta J
    Cancer; 2004 Jun; 100(11):2456-61. PubMed ID: 15160352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia.
    Robertson MJ; Socinski MA; Soiffer RJ; Finberg RW; Wilson C; Anderson KC; Bosserman L; Sang DN; Salkin IF; Ritz J
    Bone Marrow Transplant; 1991 Aug; 8(2):143-5. PubMed ID: 1933056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients.
    Silveira FP; Kwak EJ; Paterson DL; Pilewski JM; McCurry KR; Husain S
    J Heart Lung Transplant; 2008 Aug; 27(8):850-5. PubMed ID: 18656797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.